Paul Zheseng Lang is a San Diego, California based male Ophthalmologist who is specialized in Ophthalmology. Active license number of Paul Zheseng Lang is A181391 for Ophthalmology in California. Paul Zheseng Lang is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Paul Zheseng Lang speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
MD
Gender:
Male
Practice Address:
200 W Arbor Dr, San Diego, California, 92103-9000
Phone:
800-926-8273
Fax:
888-539-8781
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1083275952
NPI Enumeration Date:
22 Jun, 2019
NPI Last Update On:
13 Jul, 2023
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Paul Zheseng Lang are as mentioned below.
License Number
Specialization
State
Status
A181391
Ophthalmology
California
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Po Box 232410, San Diego, California
Zip:
92193-2410
Phone Number:
--
Fax Number:
--
Patients can reach Paul Zheseng Lang at 200 W Arbor Dr, San Diego, California or can call to book an appointment on 800-926-8273. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.